{"id":2848,"date":"2025-02-08T13:17:23","date_gmt":"2025-02-08T10:17:23","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=2848"},"modified":"2025-02-08T13:17:24","modified_gmt":"2025-02-08T10:17:24","slug":"sarcomatrix-to-present-its-latest-advancements-in-the-development-of-its-lead-drug-candidate-s-969","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/hi\/sarcomatrix-to-present-its-latest-advancements-in-the-development-of-its-lead-drug-candidate-s-969\/","title":{"rendered":"Sarcomatrix \u0905\u092a\u0928\u0947 \u092a\u094d\u0930\u092e\u0941\u0916 \u0914\u0937\u0927\u093f \u0909\u092e\u094d\u092e\u0940\u0926\u0935\u093e\u0930, S-969 \u0915\u0947 \u0935\u093f\u0915\u093e\u0938 \u092e\u0947\u0902 \u0905\u092a\u0928\u0940 \u0928\u0935\u0940\u0928\u0924\u092e \u092a\u094d\u0930\u0917\u0924\u093f \u092a\u094d\u0930\u0938\u094d\u0924\u0941\u0924 \u0915\u0930\u0947\u0917\u093e"},"content":{"rendered":"\n

Sarcomatrix Therapeutics, a clinical-stage biotechnology company focused on revolutionizing treatments for muscle-related diseases, today announced its participation at the 2025 BIO CEO & Investor Conference. The event, set for February 10-11, 2025, at the New York Marriott Marquis, will serve as a platform for Sarcomatrix to showcase its latest advancements in the development of its lead drug candidate, S-969. [Read More: BIO CEO & Investor Conference<\/a>]<\/p>\n\n\n\n

David Craig, CEO of Sarcomatrix, will deliver a presentation detailing the company\u2019s significant progress in preclinical development and its strategic roadmap toward initiating Phase 1 clinical trials in 2025.<\/p>\n\n\n\n

What is DMD Drug Candidate S-969?<\/h2>\n\n\n\n
\"Sarcomatrix<\/figure>\n\n\n\n

S-969, a first-in-class small molecule targeting a key kinase on the Hippo-YAP axis, has demonstrated promising potential in addressing debilitating conditions such as Duchenne muscular dystrophy (DMD), sarcopenia, and other degenerative muscle disorders.<\/p>\n\n\n\n

\u201cThis is a transformative moment for Sarcomatrix as we prepare to transition S-969 into clinical development,\u201d said David Craig. \u201cOur robust preclinical data, coupled with a clear regulatory strategy and growing investor confidence, positions 2025 as a landmark year for our company and the patients we aim to serve.\u201d<\/p>\n\n\n\n

Learn More:<\/strong> Potential Upcoming New Gene Therapies for Duchenne Muscular Dystrophy<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Sarcomatrix Therapeutics, a clinical-stage biotechnology company focused on revolutionizing treatments for muscle-related diseases, today announced its participation at the 2025 BIO CEO & Investor Conference. The event, set for February 10-11, 2025, at the New York Marriott Marquis, will serve as a platform for Sarcomatrix to showcase its latest advancements in the development of its […]<\/p>\n","protected":false},"author":1,"featured_media":2850,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[27],"tags":[250,66,249,247,248],"class_list":["post-2848","post","type-post","status-publish","format-standard","has-post-thumbnail","category-research","tag-david-craig","tag-duchenne-muscular-dystrophy","tag-s-969","tag-sarcomatrix","tag-sarcomatrix-therapeutics"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/hi\/wp-json\/wp\/v2\/posts\/2848","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/hi\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/hi\/wp-json\/wp\/v2\/comments?post=2848"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/hi\/wp-json\/wp\/v2\/posts\/2848\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/hi\/wp-json\/wp\/v2\/media\/2850"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/hi\/wp-json\/wp\/v2\/media?parent=2848"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/hi\/wp-json\/wp\/v2\/categories?post=2848"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/hi\/wp-json\/wp\/v2\/tags?post=2848"}],"curies":[{"name":"\u0921\u092c\u094d\u0932\u094d\u092f\u0942\u092a\u0940","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}